Since the AIDS pandemic began over three decades ago, more than 75 million people have been infected with HIV, and 38 million people have died. While antiretroviral drugs have had a huge impact, there is still no vaccine and no cure. Treatment must be given for life.
John Harris challenged the Gladstone community in a discussion about prolonging the human lifespan.
Thanks to the successful implementation of HIV treatment and prevention programs, we have never been closer to achieving our goal of ending new HIV infections.
amfAR has awarded $20 million to UCSF, the Gladstone Institutes, and the Blood Systems Research Institute to establish the amfAR Institute for HIV Cure Research.
Researchers from the Gladstone Institutes have shown for the first time that the protein BRCA1 is required for normal learning and memory and is depleted by Alzheimer’s disease.
Gladstone helps its diverse scientists practice their English skills in an encouraging and fun learning environment.
The regenerative medicine program at the Gladstone Institutes has attracted the attention of two global business leaders known for their innovative approach to philanthropy.
Gladstone nominated for PG&E Step Up Award in Excellence in Energy Award, one of the most highly regarded business awards in the Bay Area.
Gladstone scientists collaborate with teachers to facilitate career discussions and lab lessons for students in public high schools in San Francisco.
Gladstone established the Assay Development and Drug Discovery Core to help scientists accelerate their research into target and drug-discovery phases and move their findings into clinical trials and potential therapies for disease.
The most influential “organ” in the human body is made up of foreign cells—six pounds worth of microorganisms. Katherine Pollard studies the human microbiome to learn how it influences health and disease.
At Gladstone Institutes, we honor our veterans and celebrate their contributions to this country.
For more than three decades, the AIDS pandemic has swept the world. Different groups have been dealing with this tragedy in a variety ways. Gladstone has one of the premier HIV research teams, but others have focused their efforts on outreach, treatment, and prevention.
Undergraduate students from the UC-Historically Black Colleges and Universities Initiative Program toured Gladstone and learned about higher education and careers in science.
Nobel Prize winner Shinya Yamanaka, MD, PhD, a senior investigator at the Gladstone Institutes in San Francisco, has been elected to the National Academy of Medicine.
Jeanne Paz emphasizes that keeping an open mind and thinking outside of the box can move scientific research in new, unanticipated directions.
Gladstone has received funding from the National Institutes of Health to continue and expand two exciting projects in cardiovascular research. The funding, totaling more than $6.8 million, supports two teams of scientists and their research on congenital heart disease.
Scientists from the Gladstone Institutes have discovered that blood-derived T cells are resistant to the chief cause of cell death in HIV infection.
A new study from the Gladstone Institutes shows that a single drop of blood in the brain is sufficient to activate an autoimmune response akin to multiple sclerosis (MS).
Gladstone is dedicated to training the next generation of scientists—not just trainees within its own walls, but also young students who aspire to obtain careers in the exciting world of biomedical research.
Innovative research tools are transforming the field of neuroscience, bringing us closer to much-needed cures for neurological diseases.
Gladstone celebrated National Postdoc Appreciation Week by recognizing the hard work and dedication of its postdocs who are the major engine that drives scientific research at Gladstone
Scientists from the Gladstone Institutes have provided a detailed map of how basic research translates into new treatments for deadly diseases.
A fast and powerful new gene-editing technology is changing biomedical research, and it has the potential to do much more. But before we start using this method to rewrite genomes outside of the laboratory, several key questions need to be answered.
By repurposing a prescription drug used to treat rheumatoid arthritis, researchers at the Gladstone Institutes successfully reversed tau-related symptoms in an animal model of dementia.